Tien Yin WONG

Executive Director, Singapore Eye Research Institute, Singapore National Eye Centre
Provost’s Chair Professor and Chairman, Department of Ophthalmology, National University of Singapore
Chief of Ophthalmology, National University Hospital


Dr Wong directs multi-disciplinary research programs with a staff of approximately 50+, comprising two Associate Professors, several Assistant Professors/Lecturers, postdoctoral research fellows, clinical fellows, graduate students, epidemiologists, a team of statisticians and database management, and clinical trials and research assistants. His research is supported by >US$30M in peer-reviewed grant funding from National Institutes of Health (NIH), USA, the National Health and Medical Research Council (NH&MRC), Australia, the Biomedical Medical Research Council (BMRC) and National Medical Research Council (NMRC), Singapore.

1. Retinal Vascular Imaging as a Biological Tool to Study Human Diseases

The objectives of this program, based concurrently at the Singapore Advanced Imaging Laboratory of Ocular Imaging (SAILOR), Singapore and Retinal Vascular Imaging Centre (RetVIC), Melbourne, are to develop state of the art ocular imaging methods to measure retinal vascular changes and other features and to correlate these changes with systemic diseases (diabetes, hypertension, stroke and heart disease) and eye diseases (diabetic retinopathy, AMD, glaucoma).

2. Population-based Studies on Eye Diseases

The objectives of this research program, the Singapore Epidemiology of Eye Disease (SEED) Program, are to capture population data on the prevalence, incidence, risk factors and impact of major eye diseases, including myopia, angle-closure glaucoma, cataract, diabetic retinopathy and age-related macular degeneration (AMD). This program comprises several population-based studies in Singapore, such as the Singapore Malay Eye Study (SiMES), the Singapore Indian Eye Study (SINDI), the Singapore Chinese Eye Study (SCES), and the Singapore Prospective Cohort Study Program (SP2).

3. Clinical and Translational Studies on Retinal Diseases

The objectives of this research program is to determine the clinical features, risk factors, and natural history of, and new therapeutic strategies for, the major retinal diseases, including diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion. This program comprises several clinical studies in Singapore and Australia, including clinical trials.


  • 2013 ARVO Fellow (Silver Award), USA

    2011 SingHealth Outstanding Publications Award, Singapore

    2011 Johns Hopkins Bloomberg School of Public Health Knowledge of the World Award, USA

    2010 Fred Hollows Lecture, Australian Ophthalmic and Visual Sciences Meeting, Australia

    2010 President's Science Award, Singapore

    2010 Academia Opthalmologic Internationalis Member

    2010 De Ocampo Lecture, Asia Pacific Academy of Ophthalmology

    2010 National Outstanding Clinician Scientist Award, Ministry of Health, Singapore

    2009 Faculty Outstanding Researcher Award, Yong Loo Lin School of Medicine, National University Health System, Singapore

    2009 Outstanding Researcher of the Year, National University of Singapore, Singapore

    2008 Singapore Translational Researcher (STaR) Award, National Medical Research Council

    2007 Achievement Award, American Academy of Ophthalmology, USA

    2007 Colin I Johnston Lecturer, High Blood Pressure Research Council of Australia, Australia

    2007 The Australian Society for Medical Research AMGEN Medical Researcher Award, Australia

    2007 SingHealth Group CEO Excellence Award in Research Singapore

    2006 The Alcon Research Institute Award, USA

    2006 The Commonwealth Minister of Health Award for Excellence in Medical Research, Australia

    2006 Novartis Prize in Diabetes, Global Award (Young Investigator), USA

Main Menu